Article
PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
Oncogene - 18 Feb 2010
Bonadies N, Neururer Ch, Steege A, Vallabhapurapu S, Pabst T, Mueller B U
Abstract excerpt
The majority of patients with acute myeloid leukemia (AML) still die of their disease, and novel therapeutic concepts are needed. Timely expression of the hematopoietic master regulator PU.1 is crucial for normal development of myeloid and lymphoid cells. Targeted disruption of an upstream regula...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
